// App-Quantinova.ai

OC 33.5 : Anti-PF4 IgG levels in patients with VITT remain high at 7 months following vaccination and can still activate platelets

Researchers

Presenter

  • S. Montague

Principal Investigators

  • C. Smith

  • C. Lodwick

  • M. Roberts

  • G. Lowe

  • W. Lester

  • S. Watson

  • P. Nicolson

Medical Centers

  • University of Birmingham, Birmingham, UK, Birmingham, England, United Kingdom

  • University of Birmingham, Birmingham, United Kingdom

  • Worcestershire Acute Hospitals NHS Trust,Worcester,United Kingdom

  • University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom

  • University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom

  • University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK, Birmingham, England, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Immunoglobulin G

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved